Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_assertion type Assertion NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_head.
- NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_assertion description "[In some cases, the effects were dramatic, as demonstrated by an increase in CD40L expression by FK228 from 0.3% to 62% when the murine prostate cancer cell line TRAMP-C2 was transduced with Ad[CD40L].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_provenance.
- NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_assertion evidence source_evidence_literature NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_provenance.
- NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_assertion SIO_000772 21379379 NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_provenance.
- NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_assertion wasDerivedFrom befree-20150227 NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_provenance.
- NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_assertion wasGeneratedBy ECO_0000203 NP295363.RAuESGYiOW457qq9GJYYUdcW5396P8RyU2eypSjp-XvGQ130_provenance.